An In Silico Analysis Identified FZD9 as a Potential Prognostic Biomarker in Triple-Negative Breast Cancer Patients

An In Silico Analysis Identified FZD9 as a Potential Prognostic Biomarker in Triple-Negative Breast Cancer Patients

Objective:Breast cancer (BC) is the main cause of cancer-related deaths in women across the world. It can be classified into different subtypes, including triple-negative (TN), which is characterized by the absence of hormone receptors for estrogen and progesterone and the lack of the human epiderma...

Full description

Bibliographic Details
Main Authors: Daniel Rodrigues de Bastos, Mércia Patrícia Ferreira Conceição, Ana Paula Picaro Michelli, Jean Michel Rocha Sampaio Leite, Rafael André da Silva, Ricardo Cesar Cintra, Jeniffer Johana Duarte Sanchez, Cesar Augusto Sam Tiago Vilanova-Costa, Antonio Márcio Teodoro Cordeiro Silva
Format: Article
Language:English
Published: Galenos Publishing House 2021-01-01
Series:European Journal of Breast Health
Subjects:
fzd9
breast cancer
triple-negative breast cancer
in silico analysis
biomarkers
Online Access: http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/an-in-silico-i-analysis-dentified-fzd9-as-a-potent/42898

Internet

http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/an-in-silico-i-analysis-dentified-fzd9-as-a-potent/42898

Similar Items